Has changed this time “share price appreciation “ and change of control”
The Options and the Warrants are subject to performance criteria (including share price appreciation) and they are exercisable, subject to vesting, between 1 April 2027 and 10 years from the date of grant. The Options and Warrants will vest immediately on a change of control of the Company.
Anyway a £100k or so is peanuts to what is at stake with By health ,and now the Dsm deal when they launch . Typical derampers trick to focus on something that really in the long run means nothing .
Some very good press coverage after results ,thought there might be some buying because of that but because of the need for a fund raise I think people are holding back (and I don’t blame them ).
After reading the rns again Dsm definitely have no more stock ! they will be ordering soon I would think .
First time this has cropped up . “but while the Company remains in a loss-making position and / or significant growth phase, it may need to raise funds in the future to meets its working capital requirements”
If that is the last of Dsm stock ! then they now have to order new stock from Pxs for their existing customers, the next batch could be much larger even without by health ordering .. !
We know that the revenue will be roughly £800 k . The income from Sept to Dec will be telling ,I’m expecting over £400 k but you know how Pxs always seem to disappoint at results time .